XML 50 R34.htm IDEA: XBRL DOCUMENT v3.25.4
Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings per Share, Basic, by Common Class, Including Two Class Method
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share (in thousands, except share and per share data):
Year Ended December 31,
202520242023
(in thousands, except per share data)
Numerator:
Net income (loss) attributable to common stockholders – basic
$(14,462)$12,504 $8,881 
Denominator:
Weighted average shares outstanding – basic47,008 49,213 51,760 
Options to purchase common stock— 3,722 4,037 
Restricted stock— 1,272 178 
Employee stock purchase plan shares— 87 52 
Weighted average shares outstanding – diluted47,008 54,294 56,027 
Net income (loss) per share attributable to common stockholders – diluted
$(0.31)$0.23 $0.16 
Schedule of Earnings per Share, Diluted, by Common Class, Including Two Class Method
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share (in thousands, except share and per share data):
Year Ended December 31,
202520242023
(in thousands, except per share data)
Numerator:
Net income (loss) attributable to common stockholders – basic
$(14,462)$12,504 $8,881 
Denominator:
Weighted average shares outstanding – basic47,008 49,213 51,760 
Options to purchase common stock— 3,722 4,037 
Restricted stock— 1,272 178 
Employee stock purchase plan shares— 87 52 
Weighted average shares outstanding – diluted47,008 54,294 56,027 
Net income (loss) per share attributable to common stockholders – diluted
$(0.31)$0.23 $0.16 
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
Year Ended December 31,
202520242023
Options to purchase common stock
4,4883,3542,167
Unvested restricted stock units1,9791001,106
ESPP37
Total common stock equivalents excluded from net income (loss) per share attributable to common stockholders – diluted
6,4673,4543,310